Atara Biotherapeutics $100 million at-the-market offering

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Atara Biotherapeutics, Inc. of its common stock for up to an aggregate amount of $100 million.

Based in Thousand Oaks, California, Atara is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases.

The Davis Polk corporate team included partner Emily Roberts and associate Elsie Cheang. All members of the Davis Polk team are based in the Northern California office.